Cargando…
Cellular Mechanisms Accounting for the Refractoriness of Colorectal Carcinoma to Pharmacological Treatment
SIMPLE SUMMARY: Colorectal cancer (CRC) causes a high number (more than 800,000) of deaths worldwide each year. Better methods for early diagnosis and the development of strategies to enhance the efficacy of the therapeutic approaches used to complement or substitute surgical removal of the tumor ar...
Autores principales: | Marin, Jose J.G., Macias, Rocio I.R., Monte, Maria J., Herraez, Elisa, Peleteiro-Vigil, Ana, de Blas, Beatriz Sanchez, Sanchon-Sanchez, Paula, Temprano, Alvaro G., Espinosa-Escudero, Ricardo A., Lozano, Elisa, Briz, Oscar, Romero, Marta R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7563523/ https://www.ncbi.nlm.nih.gov/pubmed/32933095 http://dx.doi.org/10.3390/cancers12092605 |
Ejemplares similares
-
Molecular Bases of Mechanisms Accounting for Drug Resistance in Gastric Adenocarcinoma
por: Marin, Jose J. G., et al.
Publicado: (2020) -
Plasma Membrane Transporters as Biomarkers and Molecular Targets in Cholangiocarcinoma
por: Marin, Jose J.G., et al.
Publicado: (2020) -
Usefulness of the MRP2 promoter to overcome the chemoresistance of gastrointestinal and liver tumors by enhancing the expression of the drug transporter OATP1B1
por: Herraez, Elisa, et al.
Publicado: (2017) -
Molecular Bases of Drug Resistance in Hepatocellular Carcinoma
por: Marin, Jose J.G., et al.
Publicado: (2020) -
Role of drug transporters in the sensitivity of acute myeloid leukemia to sorafenib
por: Macias, Rocio I.R., et al.
Publicado: (2018)